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In 1940,  we reported the successful adaptation of the SK strain of human 
poliomyelitis virus from the  rhesus  monkey to white mice by way of inter- 
mediary passage through cotton rats  (1).  A  close  relationship between the 
adapted virus and monkey poliomyelitis virus was suggested by similarities in 
the symptomatology and pathology of the infection in monkeys and rodents 
as  well  as  by  the  trend  of  serological  cross neutralization  tests.  The  SK 
routine virus, in some respects, resembled the Lansing mouse strain of polio- 
myelitis virus  previously  described  by  Armstrong  (2)  and  the  RMV  and 
Philadelphia mouse strains of poliomyelitis virus which were later adapted by 
Toomey (3).  It differed, however, from these other rodent strains in that it 
combined  an  extraordinary  degree  of  virulence  for  mice  with  little  or  no 
pathogenicity for rhesus  monkeys. 
The fact that various murine strains of poliomyelitis virus exhibit divergent 
properties need cause neither surprise  nor concern.  What differences there 
are may readily be accounted for, provided one is prepared to regard the arti- 
ficially induced  transmission  of  poliomyelitis virus  from  its  natural  to  an 
unnatural host not as a simple, straight transfer of virus but as a phenomenon 
of biological adaptation.  In this process different virus strains may lose old 
and gain new properties in proportion to the extent of the occurring transfor- 
mation.  Thus, with virus only partially adapted, residual virulence for the 
original host would be retained and blended with low virulence for the new host 
into a bivalent agent of dual pathogenicity; if, on the other hand, the adaptive 
process progresses to an ideal end point, the original virulence may conceivably 
be lost in a  total exchange against the  newly acquired virulence, leaving a 
strictly monovalent pathogenic agent. 
The SK murine virus, since the time of its isolation, has been maintained in 
two parallel lines of propagation, i.e. by serial transfer in tissue culture and 
by intracerebral passage in mice.  During more than 200 consecutive passages 
in vitro the tissue culture virus has preserved its original potency for mice and, 
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at no time, has given rise to paralysis in animals other than mice or cotton rats. 
The  mouse passage  virus,  on  the  other  hand,  during a  similar  number  of 
animal passages, has gradually increased in virulence for mice from an initial 
titer of about  1:1  million to a  maximum titer of about  1:1  billion dilution 
activity,  as  determined  by  intracerebral  tests.  When  reexamining murine 
virus of later mouse passages for pathogenicity in other laboratory animals it 
was found that this virus, after having been transmitted through 70 mouse 
passages,  was capable of producing flaccid paralysis in  guinea pigs  (4).  A 
detailed description of this guinea Pig paralysis will be found in another paper 
of the current  series of communications (5).  The present paper  offers new 
data concerning certain properties of murine virus obtained from remote mouse 
passages which have hitherto not been reported.  These data include: first, 
a reexamination of the pathogenicity of murine virus for rhesus monkeys and 
rabbits; second, an appraisal of age as a factor conditioning natural resistance 
of mice to infection and reinfection with murine virus; third, an investigation 
of seasonal fluctuations in the susceptibility of mice to murine infection; and 
fourth, further studies of the routine virus by means of immunological methods. 
Pathogenicity of Murine  Virus from Remote Mouse Passage for Monkeys and 
Rabbits 
(a)  Pathogenicity  for Rhesus Monkeys.--It will be recalled that murine virus, 
in its earlier passages, had failed to bring about paralysis in rhesus monkeys. 
However, the available data indicated that the virus, especially when intro- 
duced  by intracerebral  injection, was  not altogether harmless  for monkeys 
even though it fell short of producing typical poliomyelitis. 
After transmission through 70 mouse passages, the routine virus gave signs 
of more definite activity in the central nervous system of infected monkeys. 
Thus, of a group of 13 monkeys injected intracerebrally with brain or cord of 
paralyzed mice, 1 monkey developed extensive pareses and 5 monkeys passed 
through a  well defined encephalitic syndrome consisting of high fever, coarse 
tremor, and tonic-clonic convulsions, followed by extreme prostration which 
proved fatal in two instances.  The described symptoms, together with the 
pathological examination of the two fatal cases,  suggest that  the infectious 
agent is capable of localizing in the monkey brain with the production of an 
acute  polioencephalitis.  Yet  none  of  these  animals  can  be  said  to  have 
developed  "classical" poliomyelitis if this  diagnosis be  limited to  a  disease 
characterized by spinal localization of the virus with subsequent production 
of  flaccid  paralysis.  Moreover,  the  observed  process  differed  from  true 
poliomyelitis in that  transmission to new monkeys failed, whereas transfers 
to mice were positive; furthermore, monkeys which were permitted to survive 
failed to resist subsequent reinfection, 4 weeks later, with SK monkey polio- 
myelitis virus. 
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rhesus monkeys are available from experiments in which rhesus monkeys received 
a series of repeated injections of large doses of mouse virus by the intravenous 
route, extending over a period of 5 days.  These experiments will be reported 
in detail elsewhere.  Suffice it to state here that in a group of 14 monkeys thus 
treated  there  were  2  animals  which  presented  partial  or  complete  flaccid 
paralysis, strictly limited to the right leg, on the 5th day when the last dose of 
murine virus was injected.  Upon intracerebral reinfection with poliomyelitis 
monkey virus (0.5 cc.  1:10 dilution of RMV strain) both animals developed 
renewed  paralysis.  However,  whereas  paralysis  in  one  monkey  was 
generalized, involving the arms as well as the legs, the other animal became 
paralyzed only in the arms, the healthy leg remaining unaffected. 
At the time these observations were made it was thought conceivable that 
repeated  intravenous  injections of massive  doses of virus  might  serve as  a 
means to transmit poliomyelitis virus directly from the monkey to mice and 
guinea pigs.  Several experiments, however, in which this method was used in 
an effort to acclimatize the RMV and Aycock strains of monkey poliomyelitis 
virus to mice and guinea pigs led to negative results. 
(b)  Pathogenicity  for  Rabbits.--One  of  the  outstanding  characteristics  of 
the murine virus, at the time of its isolation, was its complete lack of patho- 
genicity for  rabbits.  It  therefore seemed  of  interest  to  reexamine  murine 
virus from remote mouse passages for its capacity to induce paralysis in rabbits. 
Five rabbits (1500 gin. weight)  were injected intracerebrally with 0.4 ce. of a  10 
per cent mouse brain suspension  (70th to 100th mouse passage).  During a period of 
careful observation, extending over 3 weeks, none of these animals showed any signs 
of disease. 
The experience of the foregoing experiments may be summarized by saying 
that prolonged passage of routine virus through mice apparently is associated 
with an appreciable change in biological properties.  This change manifests 
itself chiefly in an increased potency for mice and, at the same time, in a broader 
range of virulence for other rodent hosts. ~  The original lack of pathogenicity 
for rabbits,  on the other hand,  remained entirely unaffected.  As  far as  its 
pathogenic power for rhesus monkeys is concerned, continued mouse passage 
seems to have brought about a better ability of murine virus to localize in the 
central nervous system, particularly  the  brain,  of monkeys following intra- 
cerebral injection.  The fact that repeated peripheral introduction of massive 
doses of virus may cause, on occasion, typical flaccid paralysis must also be 
recognized.  The  routine  virus,  therefore,  aIthough  incapable  of producing 
regularly typical poliomyelitis, must  still be regarded as  an infectious agent 
with limited pathogenic properties for the rhesus monkey. 
It May  be  mentioned in  this  connection that  routine  virus  harvested from 
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Age Resistance of Mice to Infection with Murine Virus 
The influence of age on the susceptibility of mice to infection with various 
neurotropic viruses  has been  made the subject of recent extensive  investiga- 
tions.  The sum total of this work indicates that there develops  in growing 
mice a  well marked resistance to peripheral infection which can clearly be 
demonstrated with  such  viruses  as  equine  encephalomyditis (6),  vesicular 
stomatitis (7),  and rabies  (8);  in  no  case  could  any difference be  detected 
between young and old mice in their susceptibility to intracerebral injection 
of virus.  It was therefore suggested  that the resistance  acquired with age in 
animals which  had  experienced  no  previous  immunizing contact  with  the 
infectious agent is caused by the development and perfection of physiological 
barriers  which  serve  to  arrest  centripetal progression  of  the  virus  from a 
peripheral point of injection.  The virus of "spontaneous mouse  encephalo- 
myelitis" appears to be quite different in this respect  since an increased  re- 
sistance  with age  is  demonstrable in mice  irrespective  of whether virus  is 
introduced by the intracerebral or the intranasal route (9).  This difference 
is probably due to the fact that the protective mechanism against Theiler's 
virus  represents  a  specific form  of latent  immunity which  is  acquired  by 
previous  contact with the particular virus. 
Owing to the absence of susceptible small laboratory animals it has hereto- 
fore been impossible to study age resistance  to poliomyelitis virus by suitable 
experimental methods; it was therefore decided to investigate this problem  in 
mice infected with murine virus.  Swiss  mice, representing three different age 
groups,  according  to weight, received graded doses of murine virus by intra- 
cerebral  injection or by various peripheral routes, including  intraperitoneal, 
intranasal, and oral injections.  The incidence  of paralysis and the average 
incubation period are given in Table I. 
It will be seen from Table I that no appreciable  difference exists in the re- 
sponse of the three age groups  of mice  to intracerebral injection of murine 
virus as measured by the incidence of paralysis and the average length of the 
incubation period.  The  disease  thus  produced  was  fatal with  remarkable 
uniformity in all animals.  However,  when the results of peripheral  infection 
of virus are compared between the oldest group of mice and the two younger 
groups a marked difference in susceptibility becomes readily apparent.  Thus, 
whereas the incidence of paralysis among the youngest and the intermediate 
groups,  throughout the entire range of virus dilutions, remained at  100  per 
cent, or close to 100 per cent, for all three peripheral routes (intraperitoneal, 
intranasal, feeding), the percentage of paralyzed mice in the oldest age group 
dropped sharply with each  successive dilution of virus; in fact, almost half 
of all older  mice survived peripheral  infection with the smallest amounts of 
virus without showing any symptoms of the disease.  The above data there- 
fore indicate that the central nervous system of old mice remains fully suscepti- C.  W.  JUNGEBLUT, M.  SANDERS, AND R.  R.  ~EINER  615 
ble to infection with murine virus but  that  the  advance  in  age is associated 
with  the  development  of a  relative  resistance  to peripheral  infection  which 
seems  to  operate best when virus is introduced by the nasal route. 
For the  second part  of this  experiment  it  seemed  of interest  to determine 
whether  old mice, which had survived infection by various peripheral  routes, 
possessed any increased resistance towards peripheral reinfection with doses of 
virus large enough to paralyze all normal control animals of similar age.  Ac- 
T~LEI 
Inf~gonwithMurineVir~byVariousRo~inM~e~D~rentAge~oups 
Route of infection 
Intracerebral 
Intraperitoneal 
Intranasal 
Feeding (by 
gavage) 
Virus 
[lutio'. 
10-6 
10-6 
10-7 
lO-S 
10  -~  23 
10  -3  56 
10  -4  59 
10  -5  12 
10  ~  10 
10  ~  12 
i0  -3  8 
10  -4  12 
10  --~  16 
12~15 gin. mice 
No. of 
mice 
70 
402* 
16 
16 
Paraly-  Incu- 
bation 
sis  period 
~er ¢tnt  days 
100  2-3 
100  2-3 
100  2-3 
I00  3-4 
100  34 
100  3-4 
100  3-4 
100  3-4 
100  4-5 
100  3-5 
i00  3-5 
92  4-6 
81.2  3-5 
20-25 gin. mice 
O: C 
KllC{ 
30 
30 
30 
10 
;11 
96 
85 
67 
30 
10 
10 
10 
10 
~raly  Incu.  batioz  sis  perio( 
r ten  days 
100  2-3 
100  2-4 
100  2-4 
100  3-4 
100  3-4 
100  3-5 
100  3-5 
100  4-6 
100  4-6 
100  3-6 
100  4-7 
70  4-7 
90  4-6 
30 gin.  (and over) mice 
to. of  Par.sly-  [ Incu-  •  bation  mice  sm  ] period 
ptr cent I  days 
42  I00  [  2-4 
36  100  [  2-5 
47  19002  2-5 
39  .7  3-5 
62  100  I  4 
65  98.41  4-7 
i79"  74.4  4-7 
25  68  5-7 
25  60  5-7 
25  48  4-7 
21  66.7  5-7 
15  40  5-7 
15  60  4-7 
* Unusually  large numbers of mice were available in these instances, since the brains  of 
these animals were used for the preparation  of immune sera, as described later in this paper. 
cordingly, a  total  of 42  old mice surviving from primary infection by either 
intraperitoneal,  nasal,  or  gastrointestinal  routes,  were  reinfected  intraperi- 
toneally with 0.1 cc. of 10  -2 or 10  -8 dilution of murine virus; these amounts of 
virus, in our experience, have never failed to paralyze old mice (see Table I). 
In this group of 42 reinfected old mice, only 2 mice developed paralysis, whereas 
40 mice remained free from any symptoms of disease.  The results of this ex- 
periment, therefore, indicate that symptomless murine infection induced in old 
mice, by subeffective doses of virus, is followed by the development of a strong 
immunity which protects  against  peripheral  reinfection with  the same virus. 616  RODENT  POLIOMYELITIS.  I 
Seasonal Fluctuations  in Susceptibility  of Mice to Infection with Murine Virus 
As mentioned before, the murine virus, since its isolation, has been main- 
tained  by unbroken  serial  passage  from  mouse  to  mouse.  These passages 
were carried out as routine, at the rate of two or three transfers each week, in 
Swiss mice, weighing from 12 to  15 gm.  As a  rule,  groups of 6  mice were 
used for each passage, all animals receiving 0.03 cc. of a  10  ~  dilution of virus 
(mouse brain  suspension)  by intracerebral injection.  Records which extend 
over a  considerable period  of time are  therefore available  for a  continuous 
study of the infectivity of murine virus under standard conditions of infection. 
The results obtained during  the  entire year of 1941 have been  brought  to- 
gether in Chart 1. 
OArs 
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CHART 1.  Average incubation period throughout the year 1941 of Swiss mice (12 
to 15 gin.) following intracerebral infection with a constant dose of 0.03 cc. of murine 
virus in a dilution of 10  -e.  Each column represents the average incubation period 
observed in 2 to 3 mouse passages carried out within periods  of 6 to 9 days.  The 
figures under each month indicate the total number of mice used during that period. 
The data assembled in Chart 1 indicate that the disease was uniformlyfatal in 
all mice,  there being no  survivors among a  total of 1707 animals  following 
injection with the chosen test dose of virus.  It  will be observed, however, 
that  the average incubation period in mice injected at  certain times of the 
year is  subject  to  marked  variation.  Thus,  whereas  the  incubation  period 
from January to April and,  again,  from October to December was regularly 
between  2  and  3  days,  somewhat longer incubation periods  were noted be- 
tween May and September, the most definite prolongations (4 to 5 days) oc- 
curring during the summer months of June, July, and August.  The reasons 
for this phenomenon are unknown.  To mention only one point, it is not certain 
whether the observed fluctuations should be ascribed to cyclic variations in 
virulence of the virus or to seasonal changes in susceptibility of the host, al- 
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Immunological Studies with the Murine Virus 
(a)  Serological Tests.--Previous  experiments  (1)  had  shown  that  inactiva- 
tion of murine virus, in its early mouse passages, may be obtained by in vitro 
contact  with  various  antipoliomyelitis  sera.  The  degree  of  neutralization 
demonstrable in these tests was only slight in the case of several convalescent 
monkey  sera,  but  marked  neutralization  occurred  with  one  poliomyelitis 
hyperimmune horse serum.  Conversely, neutralization tests carried out with 
antimurine sera prepared in rabbits or monkeys indicated that some of these 
sera possessed the power to inactivate the homologous (SK)  or related (Ay- 
cock) strains of monkey poliomyelitis virus while no neutralizing power could 
generally be demonstrated against the RMV virus.  To be precise, of a  total 
of 24 antimurine sera tested against SK or Aycock virus, inactivation of either 
virus occurred with exactly one-half, i.e.  12  sera,  whereas  the remaining  12 
sera showed no virucidal power.  Neutralization was therefore demonstrable, 
but far from regular in these tests. 
In view of the irregular results obtained heretofore it was decided to rein- 
vestigate the serological analysis of SK murine virus with new antisera.  The 
following immune sera  were tested  in  mice for neutralizing activity against 
murine virus: hyperimmune antimurine horse sera,  2 hyperimmune antimurine 
and anticavian  rabbit  sera,  2 sera  obtained from monkeys convalescing from 
infection with SK or Aycock poliomyelitis virus, hyperimmune antipoliomye- 
litis  horse  sera,  8  hyperimmune  anti  lymphocytic-choriomeningitis  rabbit 
serum,  4 and normal mouse, rabbit, horse, and monkey sera.  The hyperimmune 
antimurine  horse sera  were  also  tested  for neutralizing activity against  the 
RMV and the Aycock strains of poliomyelitis virus in monkeys and a  hyper- 
immune  antimurine  rabbit  serum  for neutralizing  activity against  the  WE 
strain* of lymphocytic choriomeningitis virus in mice.  Finally, hyperimmune 
antimurine horse serum and hyperimmune antipoliomyelitis horse serum were 
tested in mice for neutralizing power against the GD VII strain  5 of Theiler's 
"spontaneous mouse encephalomyelitis" virus. 
The preparation of the hyperimmune antimurine sera will be briefly outlined 
here. 
9 Acknowledgment  is gratefully made to Ledefle Laboratories for preparation of 
these sera and for financial support in connection with this phase of the work. 
8 These sera were obtained through the courtesy of Dr. J. A. Toomey from the City 
Hospital, Cleveland. 
4 This serum and virus were obtained through the courtesy of Dr. J. E. Smadel 
from The Rockefeller Institute. 
This virus was  obtained through  the courtesy of Dr. Max Theiler from The 
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Three  horses  (A2050,  A2051, A2052) were  subjected  to  the  following course of 
immunization  with  murine  vires:  4  series  of injections  were administered  over a 
period of 6 months (Feb., 1941, to July, 1941s), each series  consisting of 4 to 9 injec- 
tions given at  intervals  of 2  to 4 days during a 2 to 3 week period.  The material 
used for immunization consisted of a mixture of tissue culture routine virus with 10 
per cent mouse brain suspension prepared from paralyzed mice, in a ratio of 3 : 1 or 2:1. 
For the first series of injections formolized antigen  (0.2 per cent) was used; subse- 
quently untreated antigen was employed.  The former was injected in 100 to 200 cc. 
doses, the latter in doses increasing from 20 cc. to 250 cc.  Injections were made by 
the intravenous, intraperitoneal, and subcutaneous routes, or by combined routes, as 
was deemed most judicious at the time of each injection.  One horse (A2050)  died 
with  indefinite  symptoms after  16 injections  had  been  given;  two horses  (A2051, 
A20527) lived through the entire immunizing period and  received approximately 27 
injections.  After each series of immunizing injections  the horses were bled and their 
'sera tested for neutralizing  activity. 
In addition,  three  groups of rabbits,  each group consisting of  15 animals, were 
immunized as follows: group A with cavian virus (10 per cent brain and cord suspen- 
sion from paralyzed guinea pigs), group B  with murine virus  (10  per cent mouse 
brain suspensions from paralyzed mice); and group C with tissue culture fluid contain- 
ing murine virus.  The rabbits in groups A and B received an average of I0 to 12 
injections, by the intravenous and intraperitoneal routes, in 2 to 3 series of injections. 
For the first series formolized antigen (0.2 per cent) was injected in 5 to 20 cc. doses, 
subsequent injections of untreated antigen were given in doses increasing from 2 cc. 
to 30 cc.  Many animals in these two groups died from shock during immunization. 
The rabbits  in group C were treated similarly, except that larger doses of antigen 
were used,  the animals receiving an average of 12 to 18 injections  (10 to 50 cc. in 
the first, 5 to 100 cc. in the second and third series of injections).  This material was 
well tolerated and there were no losses in this group.  All surviving animals were bled 
after  each  series  of injections,  the  sera  pooled according to  origin and  tested  for 
neutralizing activity. 
The results obtained with the various immune sera used for this serological 
study are brought together in Tables II to VIII.  An examination of the data 
presented shows that the immunization of horses with murine virus led to the 
development  in  the  serum  of a  very high  virucidal  titer  against  this  virus 
(Tables  II  and  III).  Similarly,  antisera  produced  by  the  immunization  of 
rabbits  with either  murine or cavian virus were capable of inactivating large 
s During this time these animals also received, as routine preventative measures, 
two injections of equine encephalomyelitis chick vaccine and tetanus toxoid. 
v It should be mentioned that one horse  (A2052),  9 days after termination  of the 
'last series  of murine virus injections, showed stumbling  of the front legs.  One week 
later progressive flaccid paralysis of the posterior quarters was noted.  The next day 
this paralysis was complete and the animal was destroyed.  No virus pathogenic for 
mice, guinea pigs, or monkeys could be recovered from the brain or cord.  The cause 
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amounts  of murine virus.  On the other hand,  a  hyperimmune  serum  against 
the  virus  of  lymphocytic  choriomeningitis  was  as  completely  devoid  of  neu- 
TABLE  II 
Titration  in Mice  of Successive  Trial Bleedings  Obtained  from  Horses  under  Immunization  ugth 
Murine  Virus  against  a  Constant  Test  Dose  (10  -8)  of  Murir~  Virus 
Serum 
Horse A2050 
1st  trial bleeding  ................ 
2nd  "  "  ................ 
3,[d  ....  . ............... 
Horse A2051 
1st  trial bleeding  ............... 
2nd  "  "  ............... 
3rd  "  "  ............... 
4th  "  "  ............... 
Horse A2052 
1st  trial bleeding  ............... 
2nd  "  " 
3rd  "  "  ................ 
4th  "  "  ................ 
5th  "  "  . ............... 
Normal horse serum 1 .............. 
Normal horse serum 2 ............. 
/irus 
lutior 
10-8 
10-8 
10-3 
10-8 
10-8 
10-8 
10-3 
10-8 
10-8 
10-8 
10-  a 
10-  8 
10-8 
10-4 
10-5 
10-* 
10-8 
10-* 
10-5 
10-6 
Un- 
.luted 
~)/3 
0/3 
0/3 
1/3 
0/3 
O/6 
1/3 
Serum dilutions 
0/3 
0/3 
1/6 
0/3 
0/7 
3/3 
3/3 
2/3 
1/3 
3/3 
3/3  I 
1/3 
1/3 
1:20  1:50 
3/3  I 
2/3 
O/3 
3/3 
1/3 
O/3 
1/3 
O/3 
O/3 
3/3[ 
3/3[ 
1/3[ 
3/3 
1/3 
O/6  0/3 
0/3  1/3 
3/3 
1/3 
1/6  0/3 
0/3  0/3 
1/7  3/7 
1:1000 
4/4 
Numerator =  number of mice paralyzed.  Denominator =  number of mice injected. 
Tecknigue.--In  preparing serum-virus mixtures, 0.5 cc. of virus dilution was added to 0.5 
cc. of undiluted or diluted serum; after incubation for 1 hour at 37°C., 0.2 cc. of each mixture 
was injected intraperitoneally into each of 3 or more mice.  The mice were observed routinely 
over a  period of  10  to  14 days; following injection of non-neutralizing mixtures paralysis 
appeared regularly within 3 to 5 days.  The same technique was used in all subsequent tests 
unless otherwise noted. 
tralizing power  against murine virus as was normal  rabbit  serum  (Table IV). 
Conversely, lymphocytic  choriomeningitis virus was not  inactivated  by  anti- 
murine  serum  (Table V).  Neutralization  tests with Aycock and  SK monkey 620  RODENT  POLIOMYELITIS.  I 
poliomyelitis-convalescent  sera  gave  irregular  results;  thus,  one  each  of  two 
Aycock and  two  SK sera  neutralized  large amounts  of murine  virus,  but  the 
other  Aycock  and  SK  sera  had  little  or  no  demonstrable  virucidal  power 
TABLE  III 
Neutralization  in Mice of Variable Doses of Murine Virus by a Constant  Amount of Undiluted 
Hyperimmune Antimurine Horse Serum 
Undiluted serum, trial bleeding after 2 series of injections 
Immune horse serum A2050 ....................... 
"  "  "  A2051 ....................... 
......  A2052 ....................... 
Normal horse serum 1 ............................ 
"  "  "  2 ............................ 
......  5 (phenolized*) ............... 
"  "  "  6 .........  ................... 
......  7 (tricresolized*) .............. 
l~t  I0-2 
2/3  0/3 
I/3  0/3 
0/3  1/3 
3/3 
3/3 
3/3 
3/3 
3/3 
3/3 
4/4 
Virus dilutions 
10-* 
0/3 
0/3 
0/3 
3/3 
3/3 
3/3 
3/3 
3/3 
3/3 
4/4 
10-4 
1/3 
0/3 
0/3 
3/3 
2/3 
3/3 
3/3 
3/3 
3/3 
4/4 
10--*  10-1 
0/3  0/3 
0/3  0/3 
0/3  0./3 
2/3  0/3 
0/3  o/3 
1/3  0/3 
1/3  0/3 
1/3  o/3 
3/3 
4/4 
Numerator -- number of mice paralyzed.  Denominator -  number of mice injected. 
* Serum 5 represents serum 4 to which sufficient phenol has been added to make a  final 
concentration of 0.5 per cent; serum 7 represents serum 6 to which sufficient tricresol has been 
added to make a final concentration of 0.3 per cent. 
TABLE IV 
Neutralization  Tests  in Mice with Murine  Virus  against  Hyperimmune  Anti Murine-,  Anti 
Cavian-,  and  Anti  Lymphocytic-Choriomeningitis  Virus  Rabbit  Sera 
Virus dilutions 
Undiluted serum 
I 
0/3  [  1/3  [0/3  0/3  [ 
0/3]0/3j0/3  0/3] 
6/6  6/6  5/6  4/6  I 
I  5/6]4/6  2/6[  I/6 
Numerator  =  number of mice paralyzed.  Denominator =  number of mice in ected. 
Anfimurine rabbit serum .............................. 
Anticavian rabbit serum ............................... 
Anti lymphocytic-choriomeningitis rabbit serum .......... 
Normal rabbit serum ................................... 
(Table  VI).  The  irregularity  of  these  results  renders  their  interpretation 
difficult, particularly since none of these sera had been tested for their ability to 
neutralize corresponding  strains of poliomyelitis virus in the monkey.  It will 
also  be  observed  that  the  second  Aycock serum,  when  run  against  an  early 
passage  of  murine  virus,  failed  to  give  clear-cut  neutralization  (Table  VI). 
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horse serum (pseudoglobulin fraction) s which proved capable, in repeated tests, 
of inactivating  comparatively large amounts  of murine  virus;  the  unrefined 
serum, on the other hand, possessed little or no neutralizing power (Table VII). 
Normal sera from various species of animals showed no neutralizing effect on 
murine virus, including sera obtained from normal adult mice and  cotton rats 
(Table vn).  By contrast,  the  same samples of adult normal mouse  serum 
brought about complete inactivation of Theiler's virus (Table vnI).  As fai as 
TABLE V 
Neutralization Tests in Mice with Lymphocytic Choriomeningitis Virus against Hyperimmune 
Anti Lymphocytic-Choriomeningitis Serum and Hyperimmune A ntimurine Rabbit Serum 
Serum 
[-Iyperimmune anti  lym- 
phocytic-choriomenin- 
gitis rabbit serum 
[-Iyperimmune antimurine 
rabbit serum 
tions  6th  [ 
10--2  -__ 
10-' 
10-4 
10-2 --+  4- -- 
lO-a-  +  +- 
10 -4  4- +  + ++ 
Days 
?th  8tb 
++4-  --D-4- 
D  ++  --D 
+++  DD++ 
9~ 
++ 
4- 
D 
10th  llth 
++  ++ 
4-  4- 
12th I 13th 
D+]  D 
+  D 
I 
14th 
--  =  no symptoms.  ++ =  marked symptoms. 
4- -- beginning illness.  D  =  dead. 
+  =  ill. 
Technique.---O.5 cc. of undiluted serum was combined with 0.5 cc. of virus dilution to give the 
final dilutions indicated in the table.  Mixtures were held for 1 hour at 37°C. and 2 hours at room 
temperature.  0.03  cc. of each mixture was injected intracerebrally into each of 3 mice. 
the neutralization of Theiler's virus by antimurine horse serum is concerned, 
it appears that this virus was definitely neutralized by antimurine horse serum 
s According to information received from Dr. Toomey, this particular serum con- 
tained 0.5  per cent phenol.  Marked neutralization had previously been obtained 
with the pseudoglobulin fraction of another antipoliomyelitis horse serum  (1).  As 
far as could be ascertained at that time the latter serum was free from any preserva- 
tive; it has since become heavily contaminated, thus precluding its further use.  The 
question has been raised (10) whether thq presence in serum of a preservative, such 
as phenol in proper concentration, might serve to bring about spurious inactivation of 
murine virus by chemical action.  To answer this question samples of normal horse 
serum  were phenolized  (0.5  per cent  concentration)  or tricresolized (0.3  per cent 
concentration) and compared for virucidal action with the untreated samples.  The 
results of this experiment are given in Table III.  They show that the addition of 
such preservatives had in no way altered the inability of normal serum to inactivate 
murine virus.  Intracerebral injection of such serum-virus mixtures into mice likewise 
failed to result in virus inactivation. 622  RODENT  POLIOMYELITIS.  I 
up  to a  titer  of  1:50 serum  dilution,  as  contrasted  with  a  titer  of approxi- 
mately 1:500 serum dilution against a  comparable dose of murine virus.  It 
is  further  evident  that  some neutralization  of Theiler's  virus occurred with 
potent antipoliomyelitis horse serum though such neutralization was in no way 
comparable with  the  marked  neutralizing  action  of the  same  serum  on  SK 
murine virus.  As far as  the neutralization  of monkey poliomyelitis virus is 
concerned, it was found that neither antimurine horse sera nor antimurine or 
anticavian rabbit sera possessed any demonstrable inactivating power against 
the SK, Aycock, or RMV virus as determined by intracerebral tests in mon- 
TABLE VI 
Neutralization  Tests  in Mice ~4tk  Murine  Virus of Remote  or Early Mouse Passages  against 
Poliomyelitis-Convalescent  Monkey Sera 
Undiluted serum 
Aycock  convalescent  serum 1  .... 
"  "  "  2 .... 
SK convalescent  serum 1 ....... 
"  "  "  2 ....... 
Normal monkey serum 1  ....... 
"  "  "  2 ....... 
Aycock  convalescent  serum 2 .... 
Normal monkey  serum 3 ....... 
Murlne virus 
used 
179th-223rd 
mouse pas- 
sage 
16th mouse 
passage 
Virus  dilutions 
10  ~ 
o/i 
3/! 
0/i 
6/¢ 
101 
0/3 
6/6 
0/3 
6/6 
3/3 
3/3 
10-4  10-4.7 
0/3 
6/6 
0/3 
6/6 
3/3 
3/3 
12/121~  9/12 
6/6  5/6  5/6  5/9  6/9 
I0  ~  10-5.:  10  ~ 
0/3 
4/6  0/3 
O/3 
6/6 
3/3  3/3 
3/3  3/3 
3/1  0/6 
2/6 
keys.  This statement is based on results obtained with a total of 32 monkey~ 
which  received  immune serum-virus  mixtures  and  14 accompanying control 
animals, none of which escaped paralysis. 
Since all neutralization tests against murine virus in mice were done by the 
intraperitoneal route,  it is pertinent  to mention here that wide discrepancies 
were  found  to  exist  between  intraperitoneal  and  intracerebral  injection  of 
similar  virus-serum mixtures.  Thus,  it has been  impossible  to  demonstrate 
neutralizing  activity of  antimurine  sera  against  either  SK  murine  virus  or 
against Thefler's virus in mice by the latter route.  The reasons for this dis- 
crepancy are not yet clear and the problem is undergoing further investigation. 
In summary, it may therefore be stated that no serological relationship was 
demonstrated between SK murine virus and the virus of lymphocytic chorio- 
meningitis.  That  some  serological  relationship  exists  between  SK  murine C.  W.  JUNGEBLUT~  M.  SANDERS~  AND  R.  R.  ~'EINER  623 
TABLE  VII 
Neutralization  Tests  in  Mice  with  Murine  Virus  against Hyperimmune  Antipoliomyelltis 
Horse Sera 
Undiluted serum* 
.096464-G .......... 
.097607-A ......... 
Normal horse serum. 
• 096464-G ....................................... 
.097607-A ....................................... 
Normal monkey serum ............................ 
.096464-G ...................................... 
.097607-A ....................................... 
Normal monkey serum  ............................ 
.097607-A ....................................... 
Normal horse serum .............................. 
Adult normal mouse serum ........................ 
.097607.A ....................................... 
Normal horse serum .............................. 
Adult normal mouse serum ........................ 
Adult  normal  cotton  rat  serum  .................... 
l0 t 
3/3 
1/3 
Virus dilutions 
lO-S  10--4  10-6  10-'6 
2/3  1/3  0/3 
1/3  0/3  0/3 
3/3  2/3  0/3 
3/3  3/3  3/3  3/3 
2/3  1/3  0/3  0/3 
3/3  3/3  3/3 
3/3  3/3  2/3  0/3 
3/3  0/3  0/3  0/3 
3/3  3/3  3/3 
3/3 
3/3 
3/3 
3/3 
3/3 
0/3  0/3  0/3 
3/3  3/3  2/3 
3/3  3/3  3/3 
o/3 
313 
3/3 
o13 
013  013  013 
313  313  1/3  113 
313  213  213 
3/3  313  313  313 
Numerator  ---- number of mice paralyzed.  Denominator =  number of mice injected. 
* These sera were obtained through the courtesy of Dr. Toomey.  Serum .097607-A is the 
pseudoglobulin fraction of .096464-G. 
TABLE  VIII 
Neutralization  Tests in Mice with  Theiler's  Virus  against Hyperimmune  Antimurine Horse 
Serum, Hyperimmune Antipoliomyelitis Horse Serum, and Adult Normal Mouse Serum 
Serum 
Antimurine horse serum .......................... 
Antipoliomyelitis horse serum (.097607-A) .......... 
Normal adult mouse serum ....................... 
Normal horse serum ............................. 
Virus 
dilu- 
tion 
10-I 
10-i 
10-x 
10-i 
Serum dilutions 
• ~u~d  1:10  [  1:50  1:I~ 
....  [ 
4/28  I  0/8  I  2/8  I  6/8 
9/16[  [  [ 
2/2°1  I  I 
2s/2Sl  I  I 
Numerator  --- number of mice paralyzed.  Denominator =  number of mice injected. 
Techn/gue.--2.0 cc. of a  10  -I dilution of Theiler-infected mouse brains (strain GD VII) were 
added to 2.0 cc. of serum; after incubation for  1 hour at 37°C., 0.4 cc. of each mixture was 
injected intraperitoneally into the designated number of mice. 624  RODENT  POLIOMYELITIS.  I 
virus and Theiler's virus of spontaneous mouse encephalomyelitis is indicated 
by the ability of antimurine serum and of potent antipoliomyelitis horse serum 
to neutralize Theiler's virus to varying extent.  On the other hand, that SK 
murine and Theiler's virus represent entirely distinct infectious agents, in so 
far as their origin is concerned, is amply  demonstrated  by  the  differential 
action of normal adult mouse serum on the two viruses.  With respect to any 
antigenic relation that  might exist between SK murine  virus and  authentic 
poliomyelitis monkey passage virus, it would appear that poliomyelitic immune 
sera are capable of bringing about a  certain degree of inactivation of murine 
virus which ranges from weak neutralization, in the case of some convalescent 
sera,  to complete neutralization with one hyperimmune serum.  These results 
are therefore very similar  to those which had previously been  reported  (1). 
Nor do they necessarily conflict with Toomey's (11) inability to demonstrate 
neutralization  in  cotton  rats  between  SK  murine  virus  and  poliomyelitis 
immune sera since the amounts of virus used were far in excess of those which, 
in our experience with mice, proved neutralizable by the same sera.  New and 
conflicting data, however, come from the fact that hyperimmune antimurine 
horse and rabbit sera failed to show any virucidal action against SK, RMV, 
or Aycock poliomyelitis virus in monkeys.  However, in view of the fact that 
antimurine sera are not even capable of inactivating murine  virus in  mice 
injected intracerebrally with serum-virus mixtures, it may be that no critical 
significance can be attached at this time to the failure of antimurine sera to 
neutralize poliomyelitis virus in monkeys by routine intracerebral tests. 
Cross Immunity  Tests.--It  had  previously been  found  that  mice  from  a 
colony immune to Theiler's virus, when infected intracerebrally or intraperi- 
toneally with  murine virus,  developed paralysis  in  the same manner  as did 
normal control mice.  In view of the significance of this observation, if correct, 
it was decided to repeat the experiment with a more virulent strain of Theiler's 
virus. 
A group of 75 young mice were inoculated intraperitoneaUy with 0.1 cc. of a 1  : 10 
dilution of mouse brain suspension prepared from mice paralyzed by Theiler's strain 
GD VII.  Within 11 days, 45 mice had developed paralysis and subsequently died of 
the disease.  Six weeks later the remaining 30 survivors, divided into three groups of 
10 animals each, were reinfected intracerebrally with the same strain of Theiler's virus 
(0.03 cc. 10-2), murine SK virus (0.03 cc. 10~), or the Lansing strain of murine virus 
(0.03 cc. 10-I),  respectively.  At the same time 30 normal mice, divided into three 
groups, were injected intracerebrally with similar doses of the three viruses for control 
purposes. 
The result of this experiment may be briefly summarized by saying that all 
Theiler-immune mice developed paralysis upon injection with any of the three 
viruses used for reinfection.  But, whereas the disease produced by either SK 
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normal controls, paralysis produced by Theiler's virus was  considerably de- 
layed in its incubation period (6 to 7 days) as compared with normal control 
mice  (2  to 4  days). 
Another  experiment  was  performed  with  Theiler-immune  mice  in  which 
reinfection was carried out by the intraperitoneal rather than the intracerebral 
route. 
Thus, among a  total of  13  mice  which  had  survived 3  successive injections of 
Theiler's virus  (0.1 cc.  10  -1  or  10  -2  intraperitoneaUy),  7  showed  no  symptoms 
whatsoever  upon  intraperitoneal  reinfection  with  Theiler's  virus  (0.1 cc.  10  -1 
intraperitoneally) whereas  the other 6 all  became paralyzed when  reinfected with 
SK murine virus (0.1 cc. 10  -4 intraperitoneally).  Of 7 normal control mice which 
received the  same  dose of Theiler's virus 5 succumbed to the disease  and all of 7 
controls injected with SK murine virus developed paralysis. 
It  may therefore be concluded from these two experiments that  previous 
infection with  Theiler's virus had left the surviving mice with a  relative or 
absolute resistance to reinfection with the same virus but that no cross protec- 
tion whatsoever had been induced against reinfection with the two strains  of 
murine poliomyelitis virus. 
DISCUSSION 
Sufficient time seems to have elapsed since the transfer of SK poliomyelitis 
virus from the monkey to rodent hosts to attempt a  critical appraisal  and, if 
possible, some coordination of the data obtained so far in the course of this 
investigation.  Most important among the many unsettled issues is, of course, 
the question of the nature of the murine virus.  Is this virus true poliomyelitis 
virus in mice, possibly a mutant or variant of the SK monkey strain but other- 
wise embodying its essential properties, or are we dealing with another neuro- 
tropic virus, either well established or new, which was introduced by accident 
as a contaminant during the passages from monkeys to cotton rats and white 
mice?  This  question  may  be  legitimately posed  because  SK  murine  virus 
differs not only characteristically from SK monkey virus, but shows also certain 
discrepancies  when  compared with  other  mouse-adapted  strains  of  monkey 
poliomyelitis virus,  such  as  Armstrong's  Lansing  strain  or  the  RMV  and 
Philadelphia strains of Toomey. 
The  existing  differences revolve  around  the  degree  of  pathogenicity for 
monkeys, the level of virulence in rodents (cotton rats, albino rats, mice, and 
guinea pigs), and the extent of neutralization in vitro by poliomyelitis immune 
sera.  In general, the Armstrong (Lansing) and Toomey (Philadelphia, RMV) 
murine strains approximate  more closely, on all counts, the basic properties of 
monkey poliomyelitis virus because they combine definite monkey pathogeni- 
city with low rodent virulence and  are neutralized in  vitro  by convalescent 626  RODENT  POLIOMYELITIS.  I 
human and monkey sera.  Most of these distinguishing features, however, are 
only relative.  Thus, murine as well as cavian SK virus will, on occasion, pro- 
duce flaccid paralysis in rhesus monkeys, the virulence of cavian virus in guinea 
pigs is not appreciably higher than the virulence level of poliomyelitis virus in 
monkeys, and specific neutralization in vitro of both, cavian and routine virus, 
is demonstrable with antipoliomyelitis hyperimmune horse sera.  It is further 
significant that Toomey's (12)  recent experience with the adaptation of SK 
monkey virus has been similar to ours in that established rodent strains of this 
virus do not transfer back to the monkey.  On  the other hand,  the initial 
monkey pathogenicity of the Lansing strain of murine poliomyelitis virus is 
apparently lost with long continued mouse passages (13).  The actual signifi- 
cance of the existing differences, as a measure of similarity or dissimilarity, is 
therefore probably more apparent than real.  Certainly none of these rodent 
strains stand sufficiently apart  with regard to any of the  above mentioned 
criteria to warrant an assumption that they represent totally unrelated virus 
entities. 
As far as the possibility of confusion with any of the known viruses is con- 
cerned, the chances for a mistaken identity appear exceedingly slight.  While 
lymphocytic choriomeningitis virus may occur as a  stray virus in stocks of 
normal rodents, the symptomatology and pathology of either SK murine or 
SK cavian infection are incompatible with the picture of lymphocytic chorio- 
meningitis.  Additional evidence to the contrary comes from the serological 
data and the dissimilar particle size of the two respective viruses (14).  With 
regard to Theiler's virus of so called "spontaneous mouse encephalomyelitis" 
the necessity for a  careful differential diagnosis becomes more pressing, since 
the symptomatology, pathology, and epidemiology of that disease, as well as 
the morphology of its virus, are closely akin to simian and human poliomye- 
litis.  In view of the circumstances it is only possible to single out certain 
fundamental characteristics in the behavior in mice of Theiler's virus and of 
SK murine virus which would tend to show whether the two viruses are or are 
not identical.  Since mice are commonly exposed, early in life, to Theiler's 
virus  by virtue  of  carrying the  infectious agent  in feces a  herd  immunity 
rapidly develops which is sufficiently strong to leave only young animals uni- 
formly susceptible to infection.  Even in young mice intracerebral injection of 
virus  succeeds  better  than  peripheral  injection,  presumably  because  nerve 
tissue is slow in participating in the subclinical specific immunity.  The local 
strength of the protective mechanism is also indicated by the inability to infect 
mice with Theiler's virus from the gastrointestinal route.  While older animals 
can be infected, particularly with certain Theiler passage strains of unusually 
high virulence, massive doses are usually required to paralyze old mice with 
any degree of regularity, even when the virus is injected directly into the cen- 
tral nervous system.  By comparison, SK murine virus behaves in mice like C.  W.  JUNGEBLUT,  M.  SANDERS~  AND  R.  R.  ~'EINER  627 
any virus  which is  introduced on virgin  soil.  Thus,  SK routine virus  will 
infect young mice uniformly to a  high titer, not only by intracerebral inocu- 
lation but  by any peripheral  route  that  one may choose.  Old  mice,  when 
infected peripherally with SK routine virus,  exhibit  the  same  type of non- 
specific  age resistance  observed  with other neurotropic viruses  upon  propa- 
gation in previously unexposed herds or animals; again, in contrast to Theiler's 
virus,  there  is  no  loss  of  cerebral  susceptibility  to  murine  virus with 
age.  As  far as  the  immunological evidence is  concerned,  antimurine horse 
serum  and,  to  a  lesser  extent,  concentrated  antipoliomyelitis horse  serum 
are found to bring about some inactivation of Theiler's virus, although such 
inactivation  is  distinctly  inferior  to  that  observed  with  SK  routine  virus. 
While some serological relationship between murine  SK and Theiler's virus 
is therefore undeniable, the fact that normal adult mouse serum has no effect 
whatsoever on SK murine virus, whereas the same serum completely inacti- 
vates  Theiler's  virus,  is  of  crucial  significance in  establishing  the  different 
origin of the two viruses in question.  Some essential difference in the antigenic 
pattern of the two viruses is furthermore indicated by the results of cross im- 
munity tests which show that Theiler-immune mice remain fully susceptible to 
reinfection with murine SK virus.  To the criteria mentioned above must be 
added the divergent response that certain other animals exhibit to  infection 
with the  two viral agents.  Thus far the guinea pig and the  monkey have 
proven insusceptible to Theiler's virus.  SK murine virus, on the other hand, 
establishes itself in both monkeys and guinea pigs and is capable of producing 
paralysis, irregularly in monkeys, and regularly in guinea pigs.  The weight 
of the evidence is therefore in favor of regarding the murine strain of SK virus 
as a virus etiologically distinct from the known strains of Theiler's virus, even 
though  the  overlapping  serological  immune  reactions  suggest  some  genetic 
relationship  between  the  two  infectious agents  and,  indeed,  with  monkey 
poliomyelitis virus itself. 
The possibility that the SK murine virus originated as a hitherto unknown 
virus in cotton rats is strongly contraindicated by the fact that normal adult 
cotton rat serum is without effect on this virus; in addition, the behavior of 
SK virus in cotton rats, in all essential respects, is similar to that in mice. 
Since both SK routine and SK cavian virus were obtained as the result of 
continuous passage of SK poliomyelitis virus from the monkey to cotton rats 
and thence to white mice and guinea pigs, it remains to review the evidence in 
favor of regarding these rodent viruses as true descendants of poliomyelitis 
virus.  To begin with,  in its basic characteristics, such as symptomatology, 
pathology, and epidemiology, the disease in guinea pigs (5), and to a lesser extent 
in mice, has much in common with the disease in man or monkey.  Moreover, 
the particle size of cultured murine virus, as determined by ultrafiltration, is 
similar to that of poliomyelitis virus (14).  On the other hand, identification 628  RODENT  POLIOMYELITIS.  I 
by  serological  methods  cannot  be  considered  as  fully  established.  While 
murine virus and cavian virus are both definitely neutralized in vitro by con- 
centrated antipoliomyelitis horse sera, unconcentrated antipoliomyelitis horse 
serum or poliomyelitis-convalescent monkey sera show none or irregular neu- 
tralizing power.  Likewise, immunization of horses with murine virus leads to 
the development of a high virucidal titer against both rodent viruses with no 
demonstrable  neutralizing  activity  against  three strains  of  monkey polio- 
myelitis virus.  These observations therefore indicate the existence of certain 
quantitative  and  perhaps  qualitative  immunochemical  differences between 
monkey poliomyelitis and  SK  rodent  virus  which  cannot  be  satisfactorily 
explained at present. 
In summarizing the available data it would seem more rational, at this time, 
to place the SK murine virus in line with the other rodent strains of polio- 
myelitis virus and to accept all of them as variants of true poliomyelitis virus 
rather than to seize upon minor individual differences in an attempt to accord 
to  the  SK murine virus  an  autonomous status  as  a  new  virus.  While  the 
latter hypothesis is tenable, in principle, one would have to insist on positive 
corroborative evidence to that effect in order to justify taking such a position. 
CONCLUSIONS 
I.  SK murine virus maintained over more than 200 serial mouse passages 
increased in virulence for mice from an initial intracerebral titer of about 1:1 
million to a maximum titer of not less than 1:1 billion dilution activity. 
2.  Following  intracerebral  injection  with  murine  virus  of  remote  mouse 
passages, 5 of 13 rhesus monkeys developed a  characteristic encephalitic syn- 
drome.  Repeated  intravenous  injection  of  massive  doses  of  virus  caused 
localized flaccid paralysis in 2 of 14 monkeys. 
3.  Intracerebral injection of graded doses of murine virus into mice of differ- 
ent age groups caused fatal paralysis in young and old animals alike.  Infec- 
tion with small doses of virus by peripheral routes, while uniformly fatal to 
young mice, was foUowed by survival of almost half of the old mice. 
4.  The incubation period of the disease in young mice infected intracere- 
brally with a standard dose of murine virus, when studied throughout the period 
of 1 year, was found considerably lengthened during the summer months. 
5.  Cross neutralization tests furnished no evidence for any serological rela- 
tionship  between  SK  murine  virus  and lymphocytic choriomeningitis virus. 
Theiler's virus was found to be neutralizable by antimurine horse serum and, 
to  a  lesser  extent, by concentrated  antipoliomyelitis  horse serum; however, 
such  inactivation,  in  both  cases,  was  distinctly  inferior  to  that  occurring 
with  SK  murine  virus.  On  the  other  hand,  no  neutralization  whatsoever 
was obtained between SK murine virus and normal adult mouse serum, where- 
as  the  same  serum  completely neutralized Theiler's virus.  Mice  surviving C.  W.  JUNGEBLUT,  M.  SANDERS,  AND  R.  R.  ~FEINER  629 
infection  with  Theiler's  virus,  though  acquiring  immunity  to  this  virus, 
remained fully susceptible  to reinfection with SK murine virus. 
6.  Neutralization tests with SK murine virus against poliomyelitis-conva- 
lescent monkey sera gave irregular results, but neutralization of murine virus 
occurred  regularly  with  a  hyperimmune  antipoliomyelitis  horse  serum. 
Hyperimmune antimurine horse and rabbit sera, on the other hand, failed to 
inactivate three strains of monkey poliomyelitis virus  (SK,  RMV,  Aycock) 
by intracerebral tests in monkeys.  The same sera inactivated murine virus 
in mice by intraperitoneal, but not by intracerebral injection of virus-serum 
mixtures. 
7.  The identity of SK murine virus and its relation to other rodent strains 
of poliomyelitis virus is discussed on the basis of the available data. 
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